Biblio

Export 8 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Antihypertensive Agents  [Clear All Filters]
2022
I. Liampas, Hatzimanolis, A., Siokas, V., Yannakoulia, M., Kosmidis, M. H., Sakka, P., Hadjigeorgiou, G. M., Scarmeas, N., and Dardiotis, E., “Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort.”, J Alzheimers Dis, vol. 89, no. 2, pp. 709-719, 2022.
S. Tran, Kuruppu, S., and Rajapakse, N. W., “Chronic Renin-Angiotensin System Activation Induced Neuroinflammation: Common Mechanisms Underlying Hypertension and Dementia?”, J Alzheimers Dis, vol. 85, no. 3, pp. 943-955, 2022.
2018
W. Wharton, Goldstein, F. C., Tansey, M. G., Brown, A. L., Tharwani, S. D., Verble, D. D., Cintron, A., and Kehoe, P. G., “Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
P. G. Kehoe, Blair, P. S., Howden, B., Thomas, D. L., Malone, I. B., Horwood, J., Clement, C., Selman, L. E., Baber, H., Lane, A., Coulthard, E., Passmore, A. Peter, Fox, N. C., Wilkinson, I. B., and Ben-Shlomo, Y., “The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 803-814, 2018.
T. van Middelaar, van Dalen, J. W., van Gool, W. A., van den Born, B. - J. H., van Vught, L. A., van Charante, E. P. Moll, and Richard, E., “Visit-To-Visit Blood Pressure Variability and the Risk of Dementia in Older People.”, J Alzheimers Dis, vol. 62, no. 2, pp. 727-735, 2018.
2016
E. L. Ashby, Miners, J. S., Kehoe, P. G., and Love, S., “Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1191-203, 2016.
B. Ongali, Nicolakakis, N., Tong, X. - K., Aboulkassim, T., Imboden, H., and Hamel, E., “Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1183-95, 2016.
D. A. Nation, Ho, J., and Yew, B., “Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention.”, J Alzheimers Dis, vol. 50, no. 3, pp. 779-89, 2016.